These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24336052)

  • 1. Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules?
    O'Brien KL; Goldblatt D; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S107-8. PubMed ID: 24336052
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of the new pneumococcal conjugate vaccine in the USA.
    Baucher H
    Arch Dis Child; 2000 Nov; 83(5):396. PubMed ID: 11040145
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization.
    Loo JD; Conklin L; Fleming-Dutra KE; Knoll MD; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S161-71. PubMed ID: 24336058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal conjugate vaccine update.
    Campos-Outcalt D
    J Fam Pract; 2019 Dec; 68(10):564-566. PubMed ID: 31860700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.
    Fleming-Dutra KE; Conklin L; Loo JD; Knoll MD; Park DE; Kirk J; Goldblatt D; Whitney CG; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S152-60. PubMed ID: 24336057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the new pneumococcal conjugate vaccine.
    Holland MJ
    Pediatr Ann; 2001 Sep; 30(9):515-6. PubMed ID: 11554259
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods for a systematic review of pneumococcal conjugate vaccine dosing schedules.
    Loo JD; Conklin L; Deloria Knoll M; Fleming-Dutra KE; Park DE; Kirk J; Johnson TS; Goldblatt D; O'Brien KL; Whitney CG
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S182-7. PubMed ID: 24336060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal vaccination in Europe: schedule adherence.
    Gervaix A; Ansaldi F; Brito-Avô A; Azzari C; Knuf M; Martinón-Torres F; Tuerlinckx D; Tin Htar MT; Syrogiannopoulos GA
    Clin Ther; 2014 May; 36(5):802-12.e1. PubMed ID: 24746990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumococcal immunisation in the 21st century.
    Williams C; Masterton R
    J Infect; 2008 Jan; 56(1):13-9. PubMed ID: 17980915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine Update: Recommendation for conjugate pneumococcal and pneumococcal polysaccharide vaccines in adults older than 65 years.
    Niemi SA; Foster SL; Hayney MS
    J Am Pharm Assoc (2003); 2015; 55(2):212, 214-5. PubMed ID: 25749266
    [No Abstract]   [Full Text] [Related]  

  • 12. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Kobayashi M; Bennett NM; Gierke R; Almendares O; Moore MR; Whitney CG; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2015 Sep; 64(34):944-7. PubMed ID: 26334788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will two doses of pneumococcal conjugate vaccine be enough?
    Russell FM; Chokephaibulkit K
    Lancet Infect Dis; 2024 May; 24(5):449-451. PubMed ID: 38310907
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Tomczyk S; Bennett NM; Stoecker C; Gierke R; Moore MR; Whitney CG; Hadler S; Pilishvili T;
    MMWR Morb Mortal Wkly Rep; 2014 Sep; 63(37):822-5. PubMed ID: 25233284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.
    Deloria Knoll M; Park DE; Johnson TS; Chandir S; Nonyane BA; Conklin L; Fleming-Dutra KE; Loo JD; Goldblatt D; Whitney CG; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S119-29. PubMed ID: 24336054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 May; 32(ACS-4):1-6. PubMed ID: 16718922
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine effectiveness of the pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against clinically suspected invasive pneumococcal disease: a cluster-randomised trial.
    Palmu AA; Jokinen J; Nieminen H; Syrjänen R; Ruokokoski E; Puumalainen T; Moreira M; Schuerman L; Borys D; Kilpi TM
    Lancet Respir Med; 2014 Sep; 2(9):717-27. PubMed ID: 25127244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal polysaccharide-protein CRM197 conjugate vaccines, 7- or 9-valent, in the 2 + 1 schedule.
    Fritzell B; Fletcher MA
    Expert Rev Vaccines; 2011 Mar; 10(3):263-90. PubMed ID: 21434795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
    Zangeneh TT; Baracco G; Al-Tawfiq JA
    Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of abbreviated and delayed 7-valent pneumococcal conjugate vaccine dosing regimens.
    Mahon BE; Hsu K; Karumuri S; Kaplan SL; Mason EO; Pelton SI; ;
    Vaccine; 2006 Mar; 24(14):2514-20. PubMed ID: 16417951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.